The results revealed that IGF2BP3 high-expression is positively correlated with the JAK/STAT signaling pathway; notably, GSEA was conducted to investigate the possible mechanism by which IGF2BP3 participates in the occurrence and progression of AML (Fig. 6A). The gene discussed is IGF2BP3; the disease is acute myeloid leukemia.